HIGHLIGHTS
- who: Qingyuan Zhang and colleagues from the Institute of Molecular Virology and Immunology, Department of Microbiology and Immunology, School of, University, China have published the research: The HPV16E7 Affibody as a Novel Potential Therapeutic Agent for Treating Cervical Cancer Is Likely Internalized through Dynamin and Caveolin-1 Dependent Endocytosis, in the Journal: Biomolecules 2022, 12, 1114. of 16/06/2022
- what: The authors aimed to explore these underlying mechanisms of ZHPV16E7 384 to lay a foundation for further clinical trials. The authors used four endocytosis-related protein inhibitors: Dynasore, MBC, CPZ, and Wortmannin to treat . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.